国产药企亮相肥胖周,肥胖治疗赛道迎“中国力量”

制药网
Nov 05

2025年11月4日至7日,美国亚特兰大举办的“肥胖周”年度会议上,歌礼制药-B与恒瑞医药携重磅临床数据亮相,在这场全球肥胖治疗领域的行业盛会中,国产创新药以扎实的研究成果展现出强劲竞争力,无疑为中国创新药的国际化征程写下了浓墨重彩的一笔。恒瑞医药与美国KaileraTherapeutics公司联合公布的GLP-1/GIP双受体激动剂HRS9531注射液Ⅲ期临床试验(GEMINI-1)数据,成为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10